ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FAB Fusion Antibodies Plc

3.40
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fusion Antibodies Plc LSE:FAB London Ordinary Share GB00BDQZGK16 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.40 3.30 3.50 3.40 3.40 3.40 78,622 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.9M -2.6M -0.0272 -1.25 3.24M
Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FAB. The last closing price for Fusion Antibodies was 3.40p. Over the last year, Fusion Antibodies shares have traded in a share price range of 2.90p to 9.375p.

Fusion Antibodies currently has 95,365,564 shares in issue. The market capitalisation of Fusion Antibodies is £3.24 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -1.25.

Fusion Antibodies Share Discussion Threads

Showing 4026 to 4048 of 4200 messages
Chat Pages: 168  167  166  165  164  163  162  161  160  159  158  157  Older
DateSubjectAuthorDiscuss
15/4/2024
07:29
It’s a new technology and second strand of their Optimal programme alongside the AI

OptiPhageTM, a phage display based version of the same DNA library. OptiPhageTM uses the same DNA sequences as OptiMAL® but packages them into a more commonly used Phage display format. Only smaller antibody fragments can be screened in this way, compared to whole antibodies via OptiMAL®, but it can be run at a lower price point for the customer. The Directors believe that the provision of OptiPhageTM provides the Company with an ability to protect the premium pricing of the OptiMAL® programme whilst meeting budgetary constraints of its customers. It may also be the platform of choice for those wanting antibody fragments as their end product;

gtc1508
15/4/2024
07:23
Nice contract - not much upfront in terms of value, but royalties seems a good model
paulisi
15/4/2024
07:20
Excellent news this is the start of the recovery
bigjock36
10/4/2024
11:04
Interesting pickup today
ksddw2
04/4/2024
21:30
Good chart here !//https://x.com/darrenukdaytra1/status/1775849435609677990?s=46&t=KHNNXk1Nw1j5lyzHBSnKag
bobaxe1
02/4/2024
15:00
Just read your last 10 posts, another bot for the filter bin...
troutisout
02/4/2024
14:56
Yep fab considering delisting needs shareholder vote to agree
beatme1
02/4/2024
10:31
They do not have billions of shares
bobaxe1
02/4/2024
09:51
Bought APH , Alliance Pharma plc , growing profitable health care company
blackhorse23
02/4/2024
08:38
Hearing fab want to delist following other pharma stocks
beatme1
22/3/2024
18:56
I agree I bought at 3.73Fully funded and ready for a re-rate
bigjock36
22/3/2024
14:48
No brainier down here
bobaxe1
21/3/2024
13:36
According to the financials we have 10x cash to Mcap surly that is not so ?
bobaxe1
15/3/2024
16:03
Just topped up shows red good price not complaining
bobaxe1
14/3/2024
13:22
https://x.com/fsnantibodies/status/1768264192648171934?s=46&t=KHNNXk1Nw1j5lyzHBSnKag
bobaxe1
07/3/2024
12:19
Looking good, I think they want to take it higher
soultrading
07/3/2024
08:37
Picking up here
bobaxe1
05/3/2024
15:36
Decent 901k buy there ??
bigjock36
03/3/2024
21:16
Some decent news after placing and 7 should not be an issue
bigjock36
01/3/2024
11:19
Nice to see a bit of action back, another assault on 7s please, GLA
lawson27
01/3/2024
11:02
I have, but have been several of the larger buys since last Thursday last week, so been happy with the way the price action has gone...
troutisout
01/3/2024
09:14
Anyone else noticed a regular pattern with this. An immediate sell of a few thousand at the start of the day to weaken the price, and then multiple larger buys throughout the day
ksddw2
27/2/2024
12:33
Agree soultrading-cash roughly 60% of market cap and little snippets, like this am's deal, small as it is, all help and happy to see them them getting a few more over the next year so they can gain traction within the field. What is important here is not the amount but the fact a tiny Belfast company's antibody library is even sufficiently worthwhile that a global diagnostics company, and the US NCI would even be aware of it.
The science must be OK-all it takes is one tiny break....but they will be snapped up soon imo.

cumnor
Chat Pages: 168  167  166  165  164  163  162  161  160  159  158  157  Older

Your Recent History

Delayed Upgrade Clock